Clinical Software and Bad Decisions: The "Practice Fusion" Settlement and Its Implications
- PMID: 35403964
- PMCID: PMC9233625
- DOI: 10.1007/s11673-022-10187-7
Clinical Software and Bad Decisions: The "Practice Fusion" Settlement and Its Implications
Keywords: Clinical decision support software; Kickbacks; Opioid prescribing; Pharmaceutical companies; Whistle-blowing.
References
-
- Fader, E.D., G. Kaiser, C.J. Kutner, A. Kozicz, and B.P. Malerba. 2020. An introduction to the anti-kickback statute. In The federal anti-kickback statute and safe harbors, edited by E.D. Fader, G.R. Kaiser, C.J. Kutner, A. Kozicz, and B.P. Malerba, 1–11. ABA Book Publishing.
-
- Faunce T, Urbas G, Skillen L, Smith M. Recovering fraudulent claims for Australian federal expenditure on pharmaceuticals and medical devices. Journal of Law and Medicine. 2010;18(2):302–315. - PubMed
-
- Kenagy JJ. Regulating electronic health records through the “nuclear” threat and other enforcement options: Federal government actions to compel EHR industry changes. Health Lawyer. 2021;33(3):5.
-
- United States Attorney’s Office, District of Vermont. 2020. Justice department announces global resolution of criminal and civil investigations with opioid manufacturer Purdue Pharma. October 21. https://www.justice.gov/usao-vt/pr/justice-department-announces-global-r.... Accessed April 3, 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
